Zhang et al. [30] experimentally validated that inhibition of TRPA1 expression could enhance the sensitivity of lung cancer cells to radiation, potentially providing new targets for the combined treatment of lung cancer with radiotherapy and immunotherapy. The gene discussed is TRPA1; the disease is lung carcinoma.